Damien Bové brings an entrepreneurial and creative spirit to his role as Chief Regulator Officer. He leads ADACT’s team of global regulatory compliance experts for the electronic cigarette, vaping, CBD and hemp industries.

Nationality: English, Italian, Scottish
Year of birth: 1976
Education: Graduate in Pharmaceutical Sciences, Postgraduate in Frontiers of Medical Science
Family status: Married, two children
Leisure time: Surfing, climbing big hills, spending time with family and friends, going to music concerts and reading a good book

Studies

  • BSc (Hons) in Pharmaceutical Sciences at the University of Bradford (1996-2000)
  • MSc in Frontiers of Medical Science at the Open University (2001-03)

Further Training

  • 2000: Clinical Research Overview, Covance
  • 2003: Advanced Issues in Clinical Research, Imperial College London
  • 2006: The Lifecycle of NHS Clinical Trials, ICR
  • 2010: Advanced Therapy Regulations
  • 2014: Cancer Innovation Exchange, East Midlands Academic Health Science Network (EMAHSN)
  • 2014: Module 3 dossiers for Traditional Herbal Medicinal Products (THMP), British Herbal Medicine Association (BHMA)
  • 2016: Regulation of Herbal Medicines, Callisto Consulting Ltd

Professional Career

  • 1998-99: Academic Liaison, SmithKline Beecham
  • 2000-01: Research Assistant to Research Associate, GlaxoSmithKline
  • 2001-02: Research Assistant to Commercial Consultant
  • 2002-03: Research Assistant to Director of Emergent Product Services
  • Since 2004: Independent consultant, Medical Technologies
  • 2009-13: Director and Regulatory Officer, IDA
  • 2013-15: Director of Product Development, Yorkshire Biotec
  • 2014: Director Innovation Centre (The HUB), Charnwood Biomedical Campus
  • Since 2012: Chief Regulatory Officer, ADACT Medical Ltd

Other Work

  • 2015-18: Regulatory Officer, European Electronic Cigarette Business Association (ECCBA)
  • Since 2000: Works with the MHRA, FDA, Health Canada, EMEA and UKVIA amongst others.

Peer review

  • Since 2015: Cell and Gene Therapy Insights

Standards committees

Since May 2019: Committee member for Electronic Cigarettes and E-liquids standards (EN, CEN, ESO) at the British Standards Institute (BSI)

Memberships

  • 2003-04: Member of the Health Economics Study Group
  • Since 2007: Registered Member of the Royal Institute of Clinical Research (ICR)
  • Since 2017: Member of the UK Vaping Industry Association (UKVIA)
  • Since 2019: Member of the Information Commissioner’s Office (ICO)

Publications

European Neurological Review, 2012;7(Suppl 1), Mary Baker, Tom Isaacs, Reijo Salonen, Damien Bové, Ken Paterson, Angelo Antonini – https://touchneurology.com/access-through-partnership-a-stakeholder-dialogue/
23 Sept 2012: Speaking to in-PharmaTechnologist.com about Health Canada’s documents
2015-17: Guest columnist for Vapour Magazine
2017-18: Guest columnist for Vapouround magazine

Guest speaker / panelist

  • 7 November 2018: Regulation and compliance, CTAUK AGM
  • 16 July 2018: All-Party Parliamentary Group to discuss vaping regulation post-Brexit
  • 25 April 2019: Novel Foods, Hemp and CBD Expo, NEC Birmingham
  • 9 May 2019: Future of vape regulations and CBD, UKVIA forum, London
  • 11 July 2019: Cannabidoil: Food Supplements Special Interest Group, Consult2deliver
  • 18 July 2019: UKVIA Board meeting, campaigning for fair and appropriate regulations
  • 28 September 2019: CEN standards meeting for chemicals in vaping, Sicily
  • 2 October 2019: ISO standards, representing UKVIA, London
  • 28 October 2019: FDA PMTA public meeting

Request your call back

Please fill in the form below and our team will get back to you as soon as possible within office hours